Literature DB >> 34164317

Correlation between sonographic features and pathological findings of cervical lymph node metastasis of differentiated thyroid carcinoma.

Xiaofeng Wu1, Lihong Zhang1, Jie Sun2, Ying Huang1, Enqiao Yu2, Dongmei Gu3, Wei Wang1, Mengyao Sun1, Kai Wang1, Jie Wang1, Mengshang Hu1, Mengqi Zhou1, Jianxia Liu2, Fenglin Dong1.   

Abstract

BACKGROUND: The aim of this study is to evaluate the relationship between the sonographic features and pathological findings of cervical lymph node metastasis of differentiated thyroid carcinoma (DTC).
METHODS: A total of 49 patients who had thyroid surgery and lateral or central cervical lymph node dissection from October to December 2019 in our hospital were selected. All the lymph nodes included in the dissection were examined by intraoperative ultrasound and were divided into 5 groups according to the sonographic characteristics (A: overall hyperechoic group; B: hypoechoic with punctate hyperechoic group; C: mass hyperechoic group; D: cystic degeneration group; E: hypoechoic group without punctate hyperecho). All samples were sent to the Pathology Department according to the area of origin and classified and numbered for comparative analysis of the microscopic pathology and the sonogram.
RESULTS: A total of 120 suspicious metastatic lymph nodes were finally screened out by intraoperative ultrasound. The sonographic signs of these suspicious metastatic lymph nodes in the lateral and central regions of the neck were significantly different from the normal lymph nodes. Besides, the indicators including sensitivity, specificity, accuracy, positive predictive value and negative predictive value of intraoperative ultrasound for detecting lateral and central lymph nodes were 89.04% vs. 82.98%, 93.83% vs. 80.00%, 90.97% vs. 81.10%, 92.86% vs. 70.91%, and 90.48% vs. 88.89%, respectively. The pathological features of metastatic lymph nodes were shown as follows: group A, diffuse distribution of follicular structure; group C, focal distribution of follicular structure; group B and E, atypical follicular epithelial cells with or without papillary structure. Necrosis and liquefaction were observed in group D.
CONCLUSIONS: The relationship between sonographic features and follicular structure of metastatic lymph nodes are firmly related. A correct understanding of these features is practical to improve the diagnostic rate of conventional ultrasonography and reduce the incidences of misdiagnosis. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Thyroid carcinoma; intraoperative ultrasound; lymph node metastasis

Year:  2021        PMID: 34164317      PMCID: PMC8184372          DOI: 10.21037/gs-21-253

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  22 in total

1.  ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee.

Authors:  Franklin N Tessler; William D Middleton; Edward G Grant; Jenny K Hoang; Lincoln L Berland; Sharlene A Teefey; John J Cronan; Michael D Beland; Terry S Desser; Mary C Frates; Lynwood W Hammers; Ulrike M Hamper; Jill E Langer; Carl C Reading; Leslie M Scoutt; A Thomas Stavros
Journal:  J Am Coll Radiol       Date:  2017-04-02       Impact factor: 5.532

2.  2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer.

Authors:  L Leenhardt; M F Erdogan; L Hegedus; S J Mandel; R Paschke; T Rago; G Russ
Journal:  Eur Thyroid J       Date:  2013-09-05

3.  Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

4.  Acoustic impedance matching of medical ultrasound transducers.

Authors:  H W Persson; C H Hertz
Journal:  Ultrasonics       Date:  1985-03       Impact factor: 2.890

Review 5.  The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: A meta-analysis.

Authors:  Lian-Ming Wu; Hai-Yan Gu; Xin-Hua Qu; Jasmine Zheng; Wei Zhang; Yan Yin; Jian-Rong Xu
Journal:  Eur J Radiol       Date:  2011-05-04       Impact factor: 3.528

6.  Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.

Authors:  John M Stulak; Clive S Grant; David R Farley; Geoffrey B Thompson; Jon A van Heerden; Ian D Hay; Carl C Reading; J William Charboneau
Journal:  Arch Surg       Date:  2006-05

7.  Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer.

Authors:  Maria A Kouvaraki; Suzanne E Shapiro; Bruno D Fornage; Beth S Edeiken-Monro; Steven I Sherman; Rena Vassilopoulou-Sellin; Jeffrey E Lee; Douglas B Evans
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

8.  Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer.

Authors:  Ji Eun Ahn; Jeong Hyun Lee; Jong Sook Yi; Young Ki Shong; Seok Joon Hong; Deok Hee Lee; Choong Gon Choi; Sang Joon Kim
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

9.  Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma.

Authors:  Jong-Lyel Roh; Jae-Yong Park; Jin-Man Kim; Chang-Jun Song
Journal:  J Surg Oncol       Date:  2009-01-01       Impact factor: 3.454

Review 10.  The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.

Authors:  Gregory W Randolph; Quan-Yang Duh; Keith S Heller; Virginia A LiVolsi; Susan J Mandel; David L Steward; Ralph P Tufano; R Michael Tuttle
Journal:  Thyroid       Date:  2012-10-19       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.